CClinicalTrials.gg
CompletedNCT03270306Updated Jul 30, 2019

Eating Behaviours, Diet and Gastrointestinal Symptoms in Children With Autism Spectrum Disorders

An observational study in Autism Spectrum Disorder, sponsored by Chinese University of Hong Kong. Completed at 1 site in China. Open to participants aged 3 Years to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-30.

Sponsored by Chinese University of Hong Kong · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
130
Ages
3 Years to 6 Years
Sex
All
01

Study summary

This case-control study aims to compare the differences in eating behaviours, nutritional status, diet quality and gastrointestinal (GI) health between Chinese children aged 3-6 years with autism spectrum disorders (ASD) (n=65) and typically developing children (TDC) (n=65).

Read the detailed description

Objective: To compare the differences in eating behaviours, nutritional status, diet quality and gastrointestinal (GI) health between Chinese children aged 3-6 years with autism spectrum disorders (ASD) and typically developing children (TDC).

Hypotheses:

  1. Children with ASD will show more problematic mealtime behaviours as represented by higher scores of 'limited variety' and 'food refusal' domains of the BAMBI compared to typically developing children
  2. Children with ASD will have more GI symptoms, in particular constipation and diarrhea compared to typically developing children
  3. Children with ASD will have a lower ratio of Bacteroidetes to Firmicutes than the typical control children
  4. Children with ASD will have less desirable diet quality in terms of lower dietary index, lower dietary diversity score and lower intake of fibre, iron, calcium, zinc and vitamin C compared to typically developing children
  5. A better diet quality will be associated with a more favourable gut microbial composition in children with and without ASD

Design and subjects: Case-control study including 65 families with children of ASD and 65 families with TDC matched by child's age and sex.

Outcomes: The primary outcomes will be the difference in mean scores of 'limited variety' and 'food refusal' domains of the Chinese version of BAMBI between children with ASD and typically developing children. The secondary outcomes will be the difference in the occurrence of GI symptoms in terms of constipation and diarrhea, as well as the difference in the gut microbiota profile in terms of the Bacteroidetes to Firmicutes ratio between children with ASD and typically developing children. The tertiary outcome will be the difference in the diet quality in terms of lower dietary index, lower dietary diversity score and lower intake of fibre, iron, calcium, zinc and vitamin C in children with ASD and typically developing children.

02

Conditions studied

03

Who can participate

Ages eligible
3 Years to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Sixty five families with children of ASD of Chinese origin aged between 3 and 6 years and 65 control families with typically developing children matched by child's age (within 6 months) and sex will be recruited through invitation letters using a convenience sampling method in nurseries and kindergartens, in particular those with integrated programmes for ASD children. Some other possible channels for recruiting families with ASD children will include non-governmental organizations (NGOs) and some ASD family supporting groups.

Eligibility criteria

Inclusion Criteria for Cases:

Families with their children diagnosed with ASD by paediatrician or clinical psychologist according to the standard of the fourth or fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV or DSM-V) will be included.

Exclusion Criteria for Cases:

Families will be excluded if their children have the following conditions.

  • Diagnosed with chronic seizures
  • Suffered from recent infection 1-month prior to data and sample collection
  • With diseases or disorders that affect dietary/physical activity habits (e.g. diabetes, cystic fibrosis, cerebral palsy)
  • Usage of antibiotics and antifungal medications 1-month prior to data and sample collection
  • Currently participating or have recently participated (i.e. 1-month prior to data and sample collection) in any trials or dietary intervention programs
  • With other major medical or psychological illness, as judged by the investigators as ineligible to participate

Inclusion Criteria for Controls:

Families with typically developing children matched by child's age (i.e. within 6 months of age) and sex will be included. Children without ASD, delays in motor and language development, as well as behaviors as reported by their parents, and those do not have first-degree relatives with ASD will be included. Parents will also be asked to complete the Chinese validated version of Social Responsiveness Scale (SRS). For children who are screened with positive results, they will be further assessed by a developmental pediatrician to ascertain the autistic status. Only those who are screened negative, or those who are screened positive but subsequently ascertained by the developmental pediatrician being free from autistic symptoms will be included.

Exclusion Criteria for Controls:

The exclusion criteria will be same as those for the families with children of ASD.

04

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
130 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna
05

What researchers measure

Primary outcomes

  1. Mealtime behaviours

    Mealtime behaviours measured using the Chinese version of the Brief Autism Mealtime Behaviour Inventory

    Time frame: baseline

Secondary outcomes

  1. Gastrointestinal symptoms

    Gastrointestinal symptoms measured using the Chinese version of the Questionnaire on Pediatric Gastrointestinal Symptoms - Rome III (QPGS-RIII)

    Time frame: baseline

  2. Gut microbiota profile

    Gut microbiota profile measured using 16s sequencing

    Time frame: baseline

Other outcomes

  1. Current diet quality

    Current diet quality measured using 3-day diet record

    Time frame: baseline

  2. Usual diet quality

    Usual diet quality measured using food frequency questionnaire

    Time frame: baseline

06

Study locations

1 site
  • Chinese University of Hong Kong
    Hong Kong, China
07

Registry details

Key details

Study ID
NCT03270306
Lead sponsor
Chinese University of Hong Kong
Responsible party
Ruth Chan (Senior Research Fellow, Chinese University of Hong Kong) — Principal investigator
First posted
Sep 1, 2017
Start date
Nov 4, 2017
Primary completion
May 31, 2019
Completion
May 31, 2019
Last update
Jul 30, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion